These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 577506)

  • 1. Pharmacokinetics of methsuximide and a major metabolite in dogs.
    Dobrinska MR; Welling PG
    J Pharm Sci; 1977 May; 66(5):688-92. PubMed ID: 577506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring drug concentrations in a case of combined overdosage with primidone and methsuximide.
    Johnson GF; Least CJ; Serum JW; Solow EB; Solomon HM
    Clin Chem; 1976 Jun; 22(6):915-21. PubMed ID: 946953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The physiological disposition of 14 C-methsuximide in the rat.
    Nicholls PJ; Orton TC
    Br J Pharmacol; 1972 May; 45(1):48-59. PubMed ID: 5041507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of phensuximide, methsuximide, and their metabolites in relation to clinical efficacy.
    Porter RJ; Penry JK; Lacy JR; Newmark ME; Kupferberg HJ
    Neurology; 1979 Nov; 29(11):1509-13. PubMed ID: 116142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of methsuximide and N-desmethylmethsuximide during methsuximide therapy.
    Strong JM; Abe T; Gibbs EL; Atkinson AJ
    Neurology; 1974 Mar; 24(3):250-5. PubMed ID: 4855951
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum protein binding of desmethyl-methsuximide.
    Wad N; Bourgeois B; Krämer G
    Clin Neuropharmacol; 1999; 22(4):239-40. PubMed ID: 10442255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of beta-methyldigoxin in healthy humans I: intravenous studies.
    Hinderling PH; Garrett ER; Wester RD
    J Pharm Sci; 1977 Feb; 66(2):242-53. PubMed ID: 839422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic effects of methsuximide and mephenytoin on the delayed-matching-to-sample performance of pigeons.
    Schlinger H; Poling A
    Psychopharmacology (Berl); 1988; 95(1):82-6. PubMed ID: 3133702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a blood metabolite of methsuximide by GLC-mass spectrometry.
    Muni IA; Altshuler CH; Neicheril JC
    J Pharm Sci; 1973 Nov; 62(11):1820-3. PubMed ID: 4758080
    [No Abstract]   [Full Text] [Related]  

  • 10. Urinary metabolites of N-methyl-alpha-methyl-alpha-phenysuccinimide (methsuximide) in the dog.
    Dudley KH; Bius DL; Waldrop CD
    Drug Metab Dispos; 1974; 2(2):113-22. PubMed ID: 4150991
    [No Abstract]   [Full Text] [Related]  

  • 11. Measurement of methsuximide and N-desmethylmethsuximide using solid-phase extraction and wide-bore capillary gas chromatography.
    Cardella DS; Levtzow CB; Rifai N; Cross RE; Howlett CM; Parker NC
    Clin Biochem; 1988 Dec; 21(6):329-31. PubMed ID: 3233745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of fezolamine and its desmethyl metabolite in human plasma and urine by high-performance liquid chromatography. Intravenous pharmacokinetics in the beagle hound.
    McCoy L; Skee D; Edelson J
    J Chromatogr; 1985 Nov; 344():211-20. PubMed ID: 4086541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.
    Garrett ER; Hunt CA
    J Pharm Sci; 1977 Mar; 66(3):395-407. PubMed ID: 845807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of zopiclone.
    Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF
    Pharmacology; 1983; 27 Suppl 2():76-91. PubMed ID: 6669634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative pharmacokinetics of quinidine and its O-desmethyl metabolite in rabbits.
    Ueda CT; Nickols JG
    J Pharm Sci; 1980 Dec; 69(12):1400-3. PubMed ID: 7463324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bromopride: pharmacokinetics in dogs (author's transl)].
    Jung L; Imbs J; Koffel JC
    Arzneimittelforschung; 1982; 32(5):509-11. PubMed ID: 7201828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.
    Sponer G; Kühnle HF; Strein K; Bartsch W; Endele R; Dietmann K
    J Pharmacol Exp Ther; 1984 Jan; 228(1):235-9. PubMed ID: 6694105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
    Nakamura A; Hirota T; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of intravenous camazepam in dogs.
    Legheand J; Cuisinaud G; Bernard N; Riotte M; Sassard J
    Arzneimittelforschung; 1982; 32(7):752-6. PubMed ID: 6127087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the stereoselective pharmacokinetics of pazinaclone (DN-2327), a new anxiolytic, and its active metabolite after intravenous and oral single doses to dogs.
    Hussein Z; Mulford DJ; Bopp BA; Granneman GR
    Drug Metab Dispos; 1993; 21(5):805-10. PubMed ID: 7902240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.